Application 087811

Type
ANDA
Sponsor
VALEANT

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PHRENILINACETAMINOPHEN; BUTALBITALTABLET;ORAL325MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**NoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
53923ORIG2018-05-01